Machine learning methods in drug discovery

L Patel, T Shukla, X Huang, DW Ussery, S Wang - Molecules, 2020 - mdpi.com
The advancements of information technology and related processing techniques have
created a fertile base for progress in many scientific fields and industries. In the fields of drug …

Biomedical data and computational models for drug repositioning: a comprehensive review

H Luo, M Li, M Yang, FX Wu, Y Li… - Briefings in …, 2021 - academic.oup.com
Drug repositioning can drastically decrease the cost and duration taken by traditional drug
research and development while avoiding the occurrence of unforeseen adverse events …

[HTML][HTML] COVID-19 and cancer comorbidity: therapeutic opportunities and challenges

AS Pathania, P Prathipati, BAA Abdul, S Chava… - Theranostics, 2021 - ncbi.nlm.nih.gov
Abstract The coronavirus disease 2019 (COVID-19) is a viral disease caused by a novel
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that affects the respiratory …

Artificial intelligence, big data and machine learning approaches in precision medicine & drug discovery

A Nayarisseri, R Khandelwal, P Tanwar… - Current drug …, 2021 - ingentaconnect.com
Artificial Intelligence revolutionizes the drug development process that can quickly identify
potential biologically active compounds from millions of candidate within a short period. The …

Artificial intelligence in early drug discovery enabling precision medicine

F Boniolo, E Dorigatti, AJ Ohnmacht… - Expert Opinion on …, 2021 - Taylor & Francis
Introduction: Precision medicine is the concept of treating diseases based on environmental
factors, lifestyles, and molecular profiles of patients. This approach has been found to …

MicroRNA-small molecule association identification: from experimental results to computational models

X Chen, NN Guan, YZ Sun, JQ Li… - Briefings in bioinformatics, 2020 - academic.oup.com
Small molecule is a kind of low molecular weight organic compound with variety of
biological functions. Studies have indicated that small molecules can inhibit a specific …

Toward heterogeneous information fusion: bipartite graph convolutional networks for in silico drug repurposing

Z Wang, M Zhou, C Arnold - Bioinformatics, 2020 - academic.oup.com
Motivation Mining drug–disease association and related interactions are essential for
developing in silico drug repurposing (DR) methods and understanding underlying …

Computational drug repurposing based on electronic health records: a scoping review

N Zong, A Wen, S Moon, S Fu, L Wang, Y Zhao… - NPJ digital …, 2022 - nature.com
Computational drug repurposing methods adapt Artificial intelligence (AI) algorithms for the
discovery of new applications of approved or investigational drugs. Among the …

Drug repurposing using real-world data

GSQ Tan, EK Sloan, P Lambert, CMJ Kirkpatrick… - Drug discovery today, 2023 - Elsevier
Highlights•250 records, including 144 original studies, met the eligibility criteria for inclusion
in this review.•Studies evaluated repurposing mainly for cardiovascular disease, COVID-19 …

Systems biology based drug repositioning for development of cancer therapy

B Turanli, O Altay, J Borén, H Turkez, J Nielsen… - Seminars in cancer …, 2021 - Elsevier
Drug repositioning is a powerful method that can assists the conventional drug discovery
process by using existing drugs for treatment of a disease rather than its original indication …